1. Home
  2. IMXI vs PRTC Comparison

IMXI vs PRTC Comparison

Compare IMXI & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$15.37

Market Cap

456.2M

Sector

Technology

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

HOLD

Current Price

$16.91

Market Cap

386.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
PRTC
Founded
1994
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
456.2M
386.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IMXI
PRTC
Price
$15.37
$16.91
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$16.67
N/A
AVG Volume (30 Days)
237.6K
4.8K
Earning Date
11-10-2025
08-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.29
0.20
Revenue
$625,123,000.00
$6,391,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.95
N/A
P/E Ratio
$11.97
$7.77
Revenue Growth
N/A
1265.60
52 Week Low
$8.58
$13.30
52 Week High
$22.30
$23.35

Technical Indicators

Market Signals
Indicator
IMXI
PRTC
Relative Strength Index (RSI) 64.08 51.09
Support Level $15.06 $16.44
Resistance Level $15.51 $17.17
Average True Range (ATR) 0.08 0.35
MACD -0.00 0.12
Stochastic Oscillator 68.18 55.29

Price Performance

Historical Comparison
IMXI
PRTC

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: